| NCT ID | NCT07237191 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Articular Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 256 participants |
| Start Date | 2026-08-23 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 256 participants in total. It began in 2026-08-23 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare two types of surgical fixation in patients with specific kinds of distal femur fractures. The main questions it aims to answer is which operation for distal femur fractures is better for efficient return to work and everyday activities.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 55 years * Surgically treated displaced distal femur extra articular or complete articular fractures Exclusion Criteria: * Patients with injury features that preclude treatment with 2 implants * Patients unlikely to follow-up due to homelessness, or planning follow up at another institution * Body Mass Index (BMI) \> 40 * Injury due to ground level fall * Patient that speaks neither English or Spanish * Patients with multisystem injuries that could preclude return to work * \< 55 years of age * Prisoner
Contact & Investigator
Laurence Kempton, M.D.
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT07237191 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Articular Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07237191 currently recruiting?
Yes, NCT07237191 is actively recruiting participants. Contact the research team at laurence.kempton@wfusm.edu for enrollment information.
Where is the NCT07237191 trial being conducted?
This trial is being conducted at Charlotte, United States.
Who is sponsoring the NCT07237191 clinical trial?
NCT07237191 is sponsored by Wake Forest University Health Sciences. The principal investigator is Laurence Kempton, M.D. at Wake Forest University Health Sciences. The trial plans to enroll 256 participants.